Home › Myeloproliferative Neoplasms › Minnesota › Minneapolis
Myeloproliferative Neoplasms clinical trials in Minneapolis, MN
5 studies for Myeloproliferative Neoplasms are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi away
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi away
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
Allo HSCT Using RIC and PTCy for Hematological Diseases
RecruitingPhase 2
- Masonic Cancer Center at University of Minnesota, Minneapolis
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
RecruitingPhase 2
- Masonic Cancer Center at University of Minnesota, Minneapolis
Myeloproliferative Neoplasms trials in other cities
- Houston, TX16 studies
- New York City, NY15 studies
- Boston, MA14 studies
- Miami, FL10 studies
- Milwaukee, WI10 studies
- Baldwin Park, CA9 studies
- Seattle, WA9 studies
- Chicago, IL9 studies
- Durham, NC9 studies
- St. Louis, MO8 studies
- Cleveland, OH8 studies
- Birmingham, AL8 studies
Other studies in Minneapolis
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Ovarian Cancer23 studies
- Prostate Cancer23 studies
- Cancer (all types)22 studies
- Heart Failure21 studies
- Lung Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Colorectal Cancer19 studies
- Endometrial Cancer19 studies
- Parkinson's Disease17 studies
- Cardiovascular Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.